Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerda M Saletu-Zyhlarz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical EEG and Neuroscience|June 1, 2006
EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugsBernd Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz
Clinical EEG and Neuroscience|July 8, 2005
EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principleBernd Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
Maturitas|November 22, 2002
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patientsBernd Saletu, Peter Anderer, Doris Gruber, et al.
Human Psychopharmacology|October 31, 2002
Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolamGerda M Saletu-Zyhlarz, Peter Anderer, Peter Berger, et al.
CNS Drugs|July 13, 2016
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H Oertel, Yngve Hallström, Gerda M Saletu-Zyhlarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Comparative EEG mapping studies in Huntington's disease patients and controlsAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Journal of Neurology|December 17, 2010
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's diseaseAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trialClaudia Trenkwalder, Heike Benes, Ludger Grote, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography)Bernd Saletu, Peter Anderer, Michael Wolzt, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical EEG and Neuroscience|June 1, 2006
EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugsBernd Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz
Clinical EEG and Neuroscience|July 8, 2005
EEG mapping and low-resolution brain electromagnetic tomography (LORETA) in diagnosis and therapy of psychiatric disorders: evidence for a key-lock principleBernd Saletu, Peter Anderer, Gerda M Saletu-Zyhlarz, et al.
Maturitas|November 22, 2002
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patientsBernd Saletu, Peter Anderer, Doris Gruber, et al.
Human Psychopharmacology|October 31, 2002
Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolamGerda M Saletu-Zyhlarz, Peter Anderer, Peter Berger, et al.
CNS Drugs|July 13, 2016
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H Oertel, Yngve Hallström, Gerda M Saletu-Zyhlarz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Comparative EEG mapping studies in Huntington's disease patients and controlsAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Journal of Neurology|December 17, 2010
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's diseaseAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trialClaudia Trenkwalder, Heike Benes, Ludger Grote, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography)Bernd Saletu, Peter Anderer, Michael Wolzt, et al.
Pageof 2